Long-Term Behavioral Changes After Cessation of Chronic Antidepressant Treatment in Olfactory Bulbectomized Rats

Biological Psychiatry

Volumn 61, Issue 8, 2007, Pages 990-995

  Breuer, Megan E ^a,b   Groenink, Lucianne ^a,b   Oosting, Ronald S ^a,b   Westenberg, Herman G M ^b   Olivier, Berend ^a,b,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cessation of treatment; depression; escitalopram; imipramine; olfactory bulbectomy; open field

Indexed keywords

ANTIDEPRESSANT AGENT; ESCITALOPRAM; IMIPRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; EXPERIMENTAL STUDY; HYPERACTIVITY; LONG TERM CARE; NONHUMAN; OLFACTORY BULBECTOMY; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; TREATMENT DURATION; TREATMENT RESPONSE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CITALOPRAM; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXPLORATORY BEHAVIOR; IMIPRAMINE; MALE; OLFACTION DISORDERS; OLFACTORY BULB; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 33947585039     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.08.032     Document Type: Article

References (42)

1. Aydemir O., Deveci A., and Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: A preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 261-265
2. Chen Z., Xu H., Haimano S., Li X., and Li X.M. Quetiapine and venlafaxine synergically regulate heme oxygenase-2 protein expression in the hippocampus of stressed rats. Neurosci Lett 389 (2005) 173-177
3. Coppell A.L., Pei Q., and Zetterstrom T.S. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44 (2003) 903-910
4. Cryan J.F., Markou A., and Lucki I. Assessing antidepressant activity in rodents: Recent developments and future needs. Trends Pharmacol Sci 23 (2002) 238-245
5. Elhwuegi A. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 28 (2003) 435-451
6. Frazer A., and Morilak D.A. What should animal models of depression model?. Neurosci Biobehav Rev 29 (2005) 515-523
7. Grecksch G., Zhou D., Franke C., Schroder U., Sabel B., Becker A., et al. Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: Behavioural correlates. Br J Pharmacol 122 (1997) 1725-1731
8. Halbreich U. Major depression is not a diagnosis, it is a departure point to differential diagnosis-clinical and hormonal considerations (A commentary and elaboration on Antonejevic's paper). Psychoneuroendocrinology 31 (2006) 16-22
9. Hashimoto K., Shimizu E., and Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 45 (2004) 104-114
10. Jancsar S.M., and Leonard B.E. Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat. Prog Neuropsychopharmacol Biol Psychiatry 8 (1984) 263-269
11. Jiang X., Xu K., Hoberman J., Tian F., Marko A., Waheed J., et al. BDNF variation and mood disorders: A novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30 (2005) 1353-1361
12. Kelly J.P., Wrynn A.S., and Leonard B.E. The olfactory bulbectomized rat as a model of depression: An update. Pharmacol Ther 74 (1997) 299-316
13. Ladd C.O., Owens M.J., and Nemeroff C.B. Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology 137 (1996) 1212-1218
14. Leonard B.E., and Tuite M. Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int Rev Neurobiol 22 (1981) 251-286
15. Lima L., and Urbina M. Serotonin transporter modulation in blood lymphocytes from patients with major depression. Cell Mol Neruobiol 22 (2002) 797-804
16. Lloyd K.G., Morselli P.L., and Bartholini G. GABA and affective disorders. Med Biol 65 (1987) 159-165
17. Lumia A.R., Teicher M.H., Salchli F., Ayers E., and Possidente B. Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res 587 (1992) 181-185
18. Maier S.F. Exposure to the stressor environment prevents the temporal dissipation of behavioral depression/learned helplessness. Biol Psychiatry 49 (2001) 763-773
19. Masini C.V., Holmes P.V., Freeman K.G., Maki A.C., and Edwards G.L. Dopamine overflow is increased in olfactory bulbectomized rats: An in-vivo microdialysis study. Physiol Behav 81 (2004) 111-119
20. McEwen B.S., and Olie J.P. Neurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptine. Mol Psychiatry 10 (2005) 525-537
21. McNish K.A., and Davis M. Olfactory bulbectomy enhances sensitization of the acoustic startle reflex produced by acute or repeated stress. Behav Neurosci 111 (1997) 80-91
22. Montgomery S.A. Fast-onset antidepressants. Int Clin Psychopharmacol 12 suppl 3 (1997) S1-S5
23. Murakami S., Imbe H., Morikawa Y., Kubo C., and Senba E. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci Res 53 (2005) 129-139
24. Noreika L., Pastor G., and Liebman J. Delayed emergence of anti-depressant efficacy following withdrawal in olfactory bulbectomized rats. Pharmacology Biochem Behav 15 (1981) 393-398
25. Norman T.R., and Olver J.S. New formulations of existing antidepressants: Advantages in the management of depression. CNS Drugs 18 (2004) 505-520
26. Porsolt R.D. Animal model of depression. Biomedicine 30 (1979) 139-140
27. Porsolt R.D., Bertin A., Blavet N., Deniel M., and Jalfre M. Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity. DATE Eur J Pharmacol 57 2-3 (1979) 201-210
28. Porsolt R.D., Bertin A., and Jalfre M. "Behavioural despair" in rats and mice: Strain differences and the effects of imipramine. Eur J Pharmacol 51 (1978) 291-294
29. Porsolt R.D., Martin P., Lenegre A., Fromage S., and Drieu K. Effects of an extract of ginko biloba (EGB 761) on "learned helplessness" and other models of stress in rodents. Pharmacol Biochem Behav 36 4 (1990) 963-971
30. Richardson J.S. Animal models of depression reflect changing views on the essence and etiology of depressive disorders in humans. Prog Neuropsychopharmacol Biol Psychiatry 15 (1991) 199-204
31. Rojo J.E., Gilbert K., Cobo J., Rodriguez-Cano E., and Vallejo J. Onset of antidepressant action: A pharmacological question?. Hum Psychopharmacol Clin Exp 20 (2005) 425-433
32. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of anti-depressants. Science 301 5634 (2003) 805-809
33. Schatzberg A.F., Haddad P., Kaplan E.M., Lejoyeux M., Rosenbaum J.F., Young A.H., and Zajecka J. Serotonin reuptake inhibitor discontinuation syndrome: A hypothetical definition. Discontinuation Consensus panel. J Clin Psychiatry 58 suppl 7 (1997) 5-10
34. Seligman M.E., Weiss J., Weinraub M., and Schulman A. Coping behavior: Learned helplessness, physiological change and learned inactivity. Behav Res Ther 18 (1980) 459-512
35. Sheline Y.I. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 54 (2003) 338-352
36. Slotkin T.A., Cousins M.M., Tate C.A., and Seidler F.J. Serotonergic cell signaling in an animal model of aging and depression: Olfactory bulbectomy elicits different adaptations in brain regions of young adult vs. aging rats. Neuropsychopharmacology 30 1 (2005) 52-57
37. Song C., and Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29 (2005) 627-647
38. Uzunova V., Wrynn A.S., Kinnunen A., Ceci M., Kohler C., and Uzunov D.P. Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat. Eur J Pharmacol 486 (2004) 31-34
39. Van der Stelt H.M., Breuer M.E., Olivier B., and Westenberg H.G. Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: An in vivo microdialysis study. Biol Psychiatry 57 (2005) 1061-1067
40. Van Hoomissen J.D., Chambliss H.O., Holmes P.V., and Dishman R.K. Effects of chronic exercise and imipramine on mRNA for BDNF after olfactory bulbectomy in rat. Brain Res 974 (2003) 228-235
41. Wieronska J.M., Papp M., and Pilc A. Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats. Pol J Pharmacol 53 (2001) 517-525
42. Willner P., Towell A., Sampson D., Sophokleous S., and Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93 3 (1987) 358-364